Teresa L. Young, See Remarks at Seres Therapeutics, Inc. (MCRB), sold 728 shares at $0.84 ($612) on 2024-08-16, disclosed to the SEC on 2024-08-19.
Scheduled sale ($612) by See Remarks under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| Filing → |
| MCRB | SELL | 2025-08-19 | $982 | — | Filing → |
| MCRB | SELL | 2025-05-19 | $459 | — | Filing → |
| MCRB | SELL | 2025-02-19 | $3K | — | Filing → |